The purpose of the chemical synthesis facility is for the contractor to synthesize and purify chemicals, chemical intermediates, drugs, steroids, and anti-fertility agents for further contraceptive…
Active Definitive Contract Awarded Last action
- Contract number
- 75N94022C00005
- Awardee
-
Regents Of The University Of Minnesota UEI KABJZBBJ4B54
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,465,812
Award facts
- Opportunity
-
- Chemical Synthesis Facility Pre-Solicitation · 75N94022R00001 · Posted Mar 4, 2022
- Contract value 55% obligated
-
- $3,580,637.00 Current, with exercised options
- $6,252,885.00 Potential, with all options
- Completion date 59% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Minneapolis, MN 55455, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $613,378 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $597,151 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $755,423 | |
| Exercise an Option | $748,914 | |
| Other Administrative Action | $0 | |
| Original award | $750,946 |
About this award
The National Institute of Child Health and Human Development awarded a definitive contract to Regents of the University of Minnesota for chemical synthesis facility services on September 29, 2022, with a ceiling value of $6.25 million and no set-aside.
The contract is cost reimbursable with no fee. The originating solicitation describes synthesis and purification of chemicals, chemical intermediates, drugs, steroids, and anti-fertility agents for government contraceptive development. Place of performance is Minneapolis, MN. The contract runs through September 28, 2029.
Government-invoiced labor through FY2025 reflects a consistent 3.2–3.7 FTE footprint. FY2023 invoiced $640,000 over 6,604 contractor hours at $96.86/hour; FY2024 invoiced $681,000 over 7,530 hours at $90.49/hour; FY2025 invoiced $739,000 with 3.7 FTEs reported. The derived hourly rate declined year-over-year. The prime self-performed all reported hours with no subcontractor labor reported through FY2025. Collaborative Drug Discovery, Inc. provides CDD Vault cloud-based drug-discovery informatics platform and API access as a subcontractor supporting chemical synthesis and contraceptive research workflows.
Description
The purpose of the chemical synthesis facility is for the contractor to synthesize and purify chemicals, chemical intermediates, drugs, steroids, and anti-fertility agents for further contraceptive development by the government.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Collaborative Drug Discovery, Inc. | $45,000 | |
| Collaborative Drug Discovery, Inc. | $36,000 |
Quick answers
Who was awarded contract 75N94022C00005?
75N94022C00005 was awarded to Regents Of The University Of Minnesota by National Institute of Child Health and Human Development (National Institutes of Health) on September 29, 2022.
How much is contract 75N94022C00005 worth?
The government has obligated $3,465,812 on 75N94022C00005. Its current value, with exercised options, is $3,580,637. Its potential value, with all options, is $6,252,885.
Was contract 75N94022C00005 competed?
The extent of competition for 75N94022C00005 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award